News
Featured News
Flexibility, creativity, and dedication to make better therapeutics are at the heart of what we do. Read more on recent updates and highlights around our contract drug manufacturing activities.
BIOVECTRA is Honoured With 2025 CDMO Leadership Award, BIOLOGICS — Industry Recognizes BIOVECTRA’s Excellence in Microbial Fermentation, Recombinant Protein Production, and Aseptic Fill-Finish Capabilities.
March 6, 2025
BIOVECTRA HONOURED TO BE NAMED ONE OF CANADA’S TOP 100 EMPLOYERS 2022
Charlottetown, P.E.I. (November 12, 2021) – BIOVECTRA is proud to be selected as one of Canada’s Top 100 Employers for 2022 and considered amongst some […]
BIOVECTRA ANNOUNCES APPOINTMENT OF GORDON C. MCCAULEY AND STEVEN M. KLOSK TO BOARD
Charlottetown, P.E.I. (October 21, 2021) – BIOVECTRA, a leading Canadian biotech and pharmaceutical CDMO has appointed Gordon C. McCauley, President and CEO of adMare BioInnovations […]
BIOVECTRA Enhances Manufacturing Capacity and Flexibility with ABEC’s CSR® Large-Scale, Single-Use Microbial Fermentation Technology
For immediate release ABEC’s Custom Single Run (CSR) fermentation solutions offer working volumes up to 1,000 liters Bethlehem, PA, USA, and Charlottetown, CANADA, September 20, […]
PhaseBio Pharmaceuticals and BIOVECTRA Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
MALVERN, Pa. & SAN DIEGO — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company […]
Major investment anchors alliance for bioscience skills and training in Atlantic Canada
Charlottetown, PE – Today the Future Skills Centre (FSC) announced the investment of $1.5 million to support the establishment of the Canadian Alliance for Skills
COVID-19: Our Obligation
\At BioVectra, we take our obligation as an essential service very seriously. […]
